The Punt domain is responsible for specific DNA and protein-protein interac
tions in a family of transcription factors which includes human AML1. Struc
tural data on the Runt domain has not yet become available, possibly due to
solubility and stability problems with expressed protein fragments. Here w
e describe the optimization and characterization of a 140-residue fragment,
containing the Punt domain of AML1, which is suitable for structural studi
es. The fragment of AML1 including amino acids 46-185 [AML1(DM)(46-185)] co
ntains a double cysteine-->serine mutation which does not affect Runt domai
n structure or DNA-binding affinity. Purified AML1 (DM)(46-185) is soluble
and optimally stable in a buffer containing 200 mM MgSO4 and 20 mM sodium p
hosphate at pH 6.0. Nuclear magnetic resonance and circular dichroism spect
roscopy indicate that the Runt domain contains beta-sheet, but little or no
alpha-helical secondary structure elements. The 45 N-terminal residues of
AML1 are unstructured and removal of the N-terminal enhances sequence-speci
fic DNA binding. The NMR spectrum of AML1 (DM)(46-185) displays a favorable
chemical shift dispersion and resolved NOE connectivities are readily iden
tified, suggesting that a structure determination of this Runt domain fragm
ent is feasible. A titration of N-15-labeled AML1 (DM)(46-185) with a 14-bp
cognate DNA duplex results in changes in the N-15 NMR heteronuclear single
quantum coherence spectrum which indicate the formation of a specific comp
lex and structural changes in the Punt domain upon DNA binding.